Works matching DE "SITAGLIPTIN"

Results: 812
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 93, doi. 10.3390/jcm9010093
    By:
    • Hirai, Hiroyuki;
    • Higa, Moritake;
    • Morimoto, Takeshi;
    • Sakuma, Mio;
    • Arasaki, Osamu;
    • Nomiyama, Takashi;
    • Node, Koichi;
    • Ueda, Shinichiro;
    • Shimabukuro, Michio
    Publication type:
    Article
    13

    Covert medication.

    Published in:
    Diabetes & Primary Care, 2015, v. 17, n. 1, p. 20
    By:
    • Mathie, Juliette;
    • Elfes, Chris
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1409, doi. 10.1111/dom.14343
    By:
    • Ahmad, Ehtasham;
    • Waller, Helen L.;
    • Sargeant, Jack A.;
    • Webb, M'Balu A.;
    • Htike, Zin Zin;
    • McCann, Gerry P.;
    • Gulsin, Gaurav;
    • Khunti, Kamlesh;
    • Yates, Tom;
    • Henson, Joseph;
    • Davies, Melanie J.;
    • Webb, David R.
    Publication type:
    Article
    34
    35
    36
    37

    Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 480, doi. 10.1111/dom.14241
    By:
    • Cardona, Saumeth;
    • Tsegka, Katerina;
    • Pasquel, Francisco J.;
    • Jacobs, Sol;
    • Halkos, Michael;
    • Keeling, W. Brent;
    • Davis, Georgia M.;
    • Fayfman, Maya;
    • Albury, Bonnie;
    • Urrutia, Maria A.;
    • Galindo, Rodolfo J.;
    • Migdal, Alexandra L.;
    • Macheers, Steven;
    • Guyton, Robert A.;
    • Vellanki, Priyathama;
    • Peng, Limin;
    • Umpierrez, Guillermo E.
    Publication type:
    Article
    38
    39
    40

    Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1869, doi. 10.1111/dom.14085
    By:
    • Kim, Sin Gon;
    • Kim, Kyoung Jin;
    • Yoon, Kun Ho;
    • Chun, Sung Wan;
    • Park, Kyong Soo;
    • Choi, Kyung Mook;
    • Lim, Soo;
    • Mok, Ji‐Oh;
    • Lee, Hyoung Woo;
    • Seo, Ji A.;
    • Cha, Bong‐Soo;
    • Kim, Mi Kyung;
    • Shon, Ho Sang;
    • Choi, Dong Seop;
    • Kim, Doo Man
    Publication type:
    Article
    41

    A randomized, open‐label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1187, doi. 10.1111/dom.14023
    By:
    • Webb, David R.;
    • Htike, Zin Zin;
    • Swarbrick, Daniel J.;
    • Brady, Emer M.;
    • Gray, Laura J.;
    • Biglands, John;
    • Gulsin, Gaurav S.;
    • Henson, Joseph;
    • Khunti, Kamlesh;
    • McCann, Gerry P.;
    • Waller, Helen L.;
    • Webb, M'Balu A.;
    • Sargeant, Jack A.;
    • Yates, Thomas;
    • Zaccardi, Francesco;
    • Davies, Melanie J.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Double‐blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1128, doi. 10.1111/dom.13626
    By:
    • Frias, Juan P.;
    • Zimmer, Zachary;
    • Lam, Raymond L.H.;
    • Amorin, Guillermo;
    • Ntabadde, Catherine;
    • Iredale, Carol;
    • O'Neill, Edward A.;
    • Engel, Samuel S.;
    • Kaufman, Keith D.;
    • Makimura, Hideo;
    • Crutchlow, Michael F.
    Publication type:
    Article
    49
    50